Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?

NCT02169596 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

74

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Coronary Syndome

Interventions

DRUG: Ticagrelor
OTHER: EndoPAT - endothelial assessment

Sponsor

Hull University Teaching Hospitals NHS Trust